Letter by Henni et al Regarding Article, "Aspirin Monotherapy Should Not Be Recommended for Cardioprotection in Patients With Symptomatic Peripheral Artery Disease"

Circulation. 2018 Mar 20;137(12):1302-1303. doi: 10.1161/CIRCULATIONAHA.117.031393.

Authors

Samir Henni¹, Nafi Ouedraogo², Pierre Abraham¹

Affiliations

¹ Department of Vascular Medicine, University Hospital of Angers and Mitovasc Institute, Angers, France (S.H., P.A.).
² Department of Physiology, University Hospital of Souro Sanou, Bobo-Dioulasso, Burkina Faso (N.O.).

PMID: 29555718
DOI: 10.1161/CIRCULATIONAHA.117.031393

No abstract available

Publication types

Letter
Comment

MeSH terms

Aspirin*
Humans
Peripheral Arterial Disease*
Platelet Aggregation Inhibitors
Ticlopidine

Substances

Platelet Aggregation Inhibitors
Ticlopidine
Aspirin